Corneal Transplantation: The Forgotten Graft

The most commonly performed transplant is that of the cornea, with 2292 corneal grafts performed in the UK in 2002–03, compared with 1775 renal transplants [ 1]. In the USA approximately 40 000 transplants are performed every year [ 2]. However this preponderance is not reflected in the amount of attention given to this transplanted tissue by the scientific community: for example up till now there have been no papers published in the American Journal of Transplantation that have cornea as a key or title word (as determined by a Medline search in December 2003). There are several reasons for this. The first is that corneal grafting is the province of ophthalmologists, who (with notable exceptions) are isolated from the transplant community. The second is that there is a widespread belief that, because of the existence of immune privilege, corneal grafts are not rejected and so there is no need for further research. As we will discuss later, this is incorrect. In this article we will seek to show that study of corneal transplantation is important in its own right, and also that it has lessons for those interested in other forms of allograft.

[1]  N. Fink,et al.  The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group. , 1995, Transplantation.

[2]  J. Shadduck,et al.  Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens , 1980, The Journal of experimental medicine.

[3]  S. Gore,et al.  INFLUENCE OF DONOR AND HISTOCOMPATIBILITY FACTORS ON CORNEAL GRAFT OUTCOME , 1994, Transplantation.

[4]  R. Lechler,et al.  TRANSFERRIN RECEPTOR-MEDIATED GENE TRANSFER TO THE CORNEAL ENDOTHELIUM1 , 2001, Transplantation.

[5]  J. Streilein Regional immunity and ocular immune privilege. , 1999, Chemical immunology.

[6]  J. Isaacs,et al.  Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium , 1999, Gene Therapy.

[7]  R. Marks,et al.  Visual, refractive, and keratometric results of radial keratotomy. Five-year follow-up. , 1984, Archives of ophthalmology.

[8]  J. Niederkorn,et al.  THE DIFFERENTIAL EFFECTS OF DONOR VERSUS HOST LANGERHANS CELLS IN THE REJECTION OF MHC‐MATCHED CORNEAL ALLOGRAFTS , 1991, Transplantation.

[9]  J. Pepose,et al.  CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. , 1997, The Journal of clinical investigation.

[10]  R. Hendricks,et al.  Identification of a novel macrophage population in the normal mouse corneal stroma. , 2002, Investigative ophthalmology & visual science.

[11]  D. E. Zirm Eine erfolgreiche totale Keratoplastik , 1906, Albrecht von Graefes Archiv für Ophthalmologie.

[12]  N. Van Rooijen,et al.  Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats. , 2000, Investigative ophthalmology & visual science.

[13]  N. Joyce,et al.  Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. , 2002, Investigative ophthalmology & visual science.

[14]  D. Roder,et al.  Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. , 1992, Ophthalmology.

[15]  D. Coster,et al.  Report from the Australian Corneal Graft Registry. , 1989, Transplantation proceedings.

[16]  D. Larkin Corneal allograft rejection. , 1994, The British journal of ophthalmology.

[17]  J. Isaacs,et al.  Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation , 2000, Clinical and experimental immunology.

[18]  M. Dallman,et al.  Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea , 1997, Gene Therapy.

[19]  J. Alvarado,et al.  Prenatal and postnatal cellularity of the human corneal endothelium. A quantitative histologic study. , 1984, Investigative ophthalmology & visual science.

[20]  D. Larkin,et al.  Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. , 2003, Investigative ophthalmology & visual science.

[21]  G. Toews,et al.  Corneal allografts fail to express Ia antigens , 1979, Nature.

[22]  M. Dana,et al.  Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. , 2002, Investigative ophthalmology & visual science.

[23]  S. Balk,et al.  References Subscriptions Permissions Email Alerts NK T Cell-Derived IL-10 Is Essential for the Differentiation of Antigen-Specific T Regulatory Cells in Systemic Tolerance , 2013 .

[24]  D. Green,et al.  Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.

[25]  D. Larkin,et al.  TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival. , 2001, Investigative ophthalmology & visual science.

[26]  D. Hodge,et al.  Ten-year postoperative results of penetrating keratoplasty. , 1998, Ophthalmology.

[27]  R. Dana,et al.  Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II–positive Dendritic Cells Derived from MHC Class II–negative Grafts , 2002, The Journal of experimental medicine.

[28]  H. Volk,et al.  Survival of corneal allografts following adenovirus-mediated gene transfer of interleukin-4 , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[29]  D. Larkin,et al.  Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection , 1997, Clinical and experimental immunology.

[30]  M. Dana,et al.  Topical interleukin 1 receptor antagonist promotes corneal transplant survival. , 1997, Transplantation.

[31]  S. Pasmans,et al.  Circulating cornea-specific antibodies in corneal disease and cornea transplantation , 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  D. Larkin,et al.  Gene transfer to ex vivo stored corneas. , 1997, Cornea.

[33]  D. Gartry,et al.  Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study , 2001, The British journal of ophthalmology.

[34]  K. Okumura,et al.  Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. , 1997, Transplantation.

[35]  N. Lemoine,et al.  Adenovirus-mediated gene delivery to the corneal endothelium. , 1996, Transplantation.

[36]  A. Matas,et al.  Prolongation Of Renal Allograft Survival In A Large Animal Model By Oral Rapamycin Monotherapy , 1995, Transplantation.

[37]  J. Niederkorn,et al.  Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. , 1991, Investigative ophthalmology & visual science.

[38]  I. Cree,et al.  Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts , 1997, Eye.

[39]  D. Coster,et al.  How successful is corneal transplantation? A report from the Australian corneal graft register , 1995, Eye.

[40]  A. D. de Vos,et al.  Cytokine mRNA expression during experimental corneal allograft rejection. , 1996, Experimental eye research.

[41]  H. Dua,et al.  Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. , 2001, Ophthalmology.

[42]  N. Joyce,et al.  Effect of overexpressing the transcription factor E2F2 on cell cycle progression in rabbit corneal endothelial cells. , 2004, Investigative ophthalmology & visual science.

[43]  W. M. Bourne Cellular Changes in Transplanted Human Corneas , 2001, Cornea.

[44]  P. Medawar Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. , 1948, British journal of experimental pathology.

[45]  Prof. Dr. A. v. Hippel,et al.  Eine neue Methode der Hornhauttransplantation , 1888, Albrecht von Graefes Archiv für Ophthalmologie.

[46]  Santa Jeremy Ono,et al.  A CIITA‐independent pathway that promotes expression of endogenous rather than exogenous peptides in immune‐privileged sites , 2004, European journal of immunology.

[47]  D. Larkin,et al.  Gene delivery to the corneal endothelium. , 2000, American journal of respiratory and critical care medicine.

[48]  J. Niederkorn,et al.  Effect of alloantibodies on corneal allograft survival. , 2002, Investigative ophthalmology & visual science.

[49]  J. Fabre Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 2001; 71: 1214. , 2001 .

[50]  M. B. Goren The Eye Bank Association of America. , 2006, Comprehensive ophthalmology update.

[51]  S. Bigger An inquiry into the possibility of transplanting the cornea, with the view of relieving blindness (hitherto deemed incurable) caused by several diseases of that structure , 1837 .

[52]  J. Niederkorn The immune privilege of corneal allografts. , 1999, Transplantation.

[53]  J. Stark,et al.  Analysis of cytokine dynamics in corneal allograft rejection , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[54]  J. Zieske,et al.  Cell cycle protein expression and proliferative status in human corneal cells. , 1996, Investigative ophthalmology & visual science.

[55]  E. Zirm Eine erfolgreiche totale Keratoplastik (A successful total keratoplasty). 1906. , 1989, Refractive & corneal surgery.

[56]  N. Ehlers,et al.  OCCURRENCE OF LYMPHOCYTOTOXIC LYMPHOCYTES AND ANTIBODIES AFTER CORNEAL TRANSPLANTATION , 1976, Acta ophthalmologica.

[57]  D F P Larkin,et al.  Antibody targeted gene transfer to endothelium , 2003, The journal of gene medicine.

[58]  D. Easty,et al.  Factors influencing the suitability of organ-cultured corneas for transplantation. , 1997, Investigative ophthalmology & visual science.

[59]  J. Niederkorn Anterior chamber-associated immune deviation. , 1999, Chemical immunology.

[60]  H. Thiel,et al.  The use of cyclosporine in high-risk keratoplasty. , 1989, American journal of ophthalmology.

[61]  D. Larkin,et al.  Cytokine and chemokine expression kinetics after corneal transplantation. , 2000, Transplantation.

[62]  D. Easty,et al.  Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection. , 1991, Investigative ophthalmology & visual science.

[63]  D. Coster,et al.  Rethinking immunological privilege: implications for corneal and limbal stem cell transplantation. , 1997, Molecular medicine today.

[64]  K. Teichmann Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection , 1999, The British journal of ophthalmology.

[65]  Andrew D Dick,et al.  Predicting endothelial cell loss and long-term corneal graft survival. , 2003, Investigative ophthalmology & visual science.

[66]  K. Sonoda,et al.  Ocular Immune Privilege and CD1d-Reactive Natural Killer T Cells , 2002, Cornea.

[67]  P. Trevor-Roper,et al.  Organization and administration of Westminster-Moorfields Eye-Bank. , 1967, The British journal of ophthalmology.

[68]  D. Larkin,et al.  Adeno-associated and Herpes Simplex Viruses as Vectors for Gene Transfer to the Corneal Endothelium , 2000, Cornea.

[69]  D. Larkin,et al.  Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. , 2002, Investigative ophthalmology & visual science.